Literature DB >> 20427558

Insights into the role of DNA methylation in disease through the use of mouse models.

Melissa Conerly1, William M Grady.   

Abstract

Epigenetics was originally defined as the interaction of genes with their environment that brings the phenotype into being. It now refers to the study of heritable changes in gene expression that occur without a change in DNA sequence. To date, the best understood epigenetic mechanisms are CpG DNA methylation and histone modifications. DNA methylation in particular has been the subject of intense interest because of its recently recognized role in disease, as well as in the development and normal function of organisms. Much of the focus of disease-related research has been on cancer because of the recognition that epigenetic alterations are common in cancer and probably cooperate with genetic alterations to drive cancer formation. Our understanding of epigenetic mechanisms in controlling gene expression has resulted from the study of cell line systems and simple model systems, such as Arabidopsis thaliana. We are now moving into an era of more complex model systems, such as transgenic and knockout mouse models, which will lead to further insight into epigenetics in development and human disease. The current models have revealed complex, tissue-specific effects of epigenetic mechanisms and have further informed our understanding of the role of DNA methylation and histone modifications on disease and development. The current state of these models is the subject of this Commentary.

Entities:  

Mesh:

Year:  2010        PMID: 20427558      PMCID: PMC2860849          DOI: 10.1242/dmm.004812

Source DB:  PubMed          Journal:  Dis Model Mech        ISSN: 1754-8403            Impact factor:   5.758


  80 in total

1.  Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling.

Authors:  Norihiro Sato; Hiroyuki Matsubayashi; Tadayoshi Abe; Noriyoshi Fukushima; Michael Goggins
Journal:  Clin Cancer Res       Date:  2005-07-01       Impact factor: 12.531

2.  Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells.

Authors:  Michael Weber; Jonathan J Davies; David Wittig; Edward J Oakeley; Michael Haase; Wan L Lam; Dirk Schübeler
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

3.  Methylation of the O6-methylguanine-DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol.

Authors:  Rana Abdel-Fattah; Adam Glick; Ishtiaq Rehman; Patrick Maiberger; Henry Hennings
Journal:  Int J Cancer       Date:  2006-02-01       Impact factor: 7.396

4.  Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis.

Authors:  Yasuhiro Yamada; Laurie Jackson-Grusby; Heinz Linhart; Alex Meissner; Amir Eden; Haijiang Lin; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-08       Impact factor: 11.205

5.  Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome.

Authors:  Yoshihide Ueda; Masaki Okano; Christine Williams; Taiping Chen; Katia Georgopoulos; En Li
Journal:  Development       Date:  2006-03       Impact factor: 6.868

6.  Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer.

Authors:  Mario F Fraga; Esteban Ballestar; Ana Villar-Garea; Manuel Boix-Chornet; Jesus Espada; Gunnar Schotta; Tiziana Bonaldi; Claire Haydon; Santiago Ropero; Kevin Petrie; N Gopalakrishna Iyer; Alberto Pérez-Rosado; Enrique Calvo; Juan A Lopez; Amparo Cano; Maria J Calasanz; Dolors Colomer; Miguel Angel Piris; Natalie Ahn; Axel Imhof; Carlos Caldas; Thomas Jenuwein; Manel Esteller
Journal:  Nat Genet       Date:  2005-03-13       Impact factor: 38.330

7.  Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.

Authors:  Chibo Hong; Alika Maunakea; Peter Jun; Andrew W Bollen; J Graeme Hodgson; David D Goldenberg; William A Weiss; Joseph F Costello
Journal:  Cancer Res       Date:  2005-05-01       Impact factor: 12.701

Review 8.  Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer.

Authors:  Steven A Belinsky
Journal:  Carcinogenesis       Date:  2005-01-20       Impact factor: 4.944

9.  Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.

Authors:  Wei-Dong Chen; Z James Han; Joel Skoletsky; Jeff Olson; Jerome Sah; Lois Myeroff; Petra Platzer; Shilong Lu; Dawn Dawson; Joseph Willis; Theresa P Pretlow; James Lutterbaugh; Lakshmi Kasturi; James K V Willson; J Sunil Rao; Anthony Shuber; Sanford D Markowitz
Journal:  J Natl Cancer Inst       Date:  2005-08-03       Impact factor: 13.506

10.  Kaiso-deficient mice show resistance to intestinal cancer.

Authors:  Anna Prokhortchouk; Owen Sansom; Jim Selfridge; Isabel M Caballero; Sergey Salozhin; Dana Aithozhina; Leandro Cerchietti; Fan Guo Meng; Leonard H Augenlicht; John M Mariadason; Brian Hendrich; Ari Melnick; Egor Prokhortchouk; Alan Clarke; Adrian Bird
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

View more
  19 in total

Review 1.  Deciphering DNA Methylation in HIV Infection.

Authors:  Thilona Arumugam; Upasana Ramphal; Theolan Adimulam; Romona Chinniah; Veron Ramsuran
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

2.  Sex-dependent regulation of cytochrome P450 family members Cyp1a1, Cyp2e1, and Cyp7b1 by methylation of DNA.

Authors:  Carlos G Penaloza; Brian Estevez; Dinah M Han; Melissa Norouzi; Richard A Lockshin; Zahra Zakeri
Journal:  FASEB J       Date:  2013-10-25       Impact factor: 5.191

Review 3.  Abnormalities of the DNA methylation mark and its machinery: an emerging cause of neurologic dysfunction.

Authors:  Jacqueline Weissman; Sakkubai Naidu; Hans T Bjornsson
Journal:  Semin Neurol       Date:  2014-09-05       Impact factor: 3.420

4.  Generating Sequencing-Based DNA Methylation Maps from Low DNA Input Samples.

Authors:  Suzan Al Momani; Euan J Rodger; Peter A Stockwell; Michael R Eccles; Aniruddha Chatterjee
Journal:  Methods Mol Biol       Date:  2022

5.  DNA methylation: A mechanism for sustained alteration of KIR4.1 expression following central nervous system insult.

Authors:  Jessica L Boni; Uri Kahanovitch; Sinifunanya E Nwaobi; Candace L Floyd; Michelle L Olsen
Journal:  Glia       Date:  2020-02-18       Impact factor: 7.452

Review 6.  Cigarette smoke-induced alterations in blood: A review of research on DNA methylation and gene expression.

Authors:  Constanza P Silva; Helen M Kamens
Journal:  Exp Clin Psychopharmacol       Date:  2020-07-13       Impact factor: 3.157

7.  Gene Body Methylation of the Lymphocyte-Specific Gene CARD11 Results in Its Overexpression and Regulates Cancer mTOR Signaling.

Authors:  Michael H McGuire; Santosh K Dasari; Hui Yao; Yunfei Wen; Lingegowda S Mangala; Emine Bayraktar; Wencai Ma; Cristina Ivan; Einav Shoshan; Sherry Y Wu; Eric Jonasch; Menashe Bar-Eli; Jing Wang; Keith A Baggerly; Anil K Sood
Journal:  Mol Cancer Res       Date:  2021-08-04       Impact factor: 5.852

8.  Comparison of the genome-wide DNA methylation profiles between fast-growing and slow-growing broilers.

Authors:  Yongsheng Hu; Haiping Xu; Zhenhui Li; Xuejuan Zheng; Xinzheng Jia; Qinghua Nie; Xiquan Zhang
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

9.  Predicting the progress of colon cancer by DNA methylation markers of the p16 gene in feces - Evidence from an animal model.

Authors:  Wen-Chih Wu; Chih-Hsiung Hsu; Jen-Chun Kuan; Jih-Fu Hsieh; Chien-An Sun; Tsan Yang; Chang-Chieh Wu; Yu-Ching Chou
Journal:  Genet Mol Biol       Date:  2013-08-30       Impact factor: 1.771

10.  mRNA expression and hypermethylation of tumor suppressor genes apoptosis protease activating factor-1 and death-associated protein kinase in oral squamous cell carcinoma.

Authors:  Chunyan Li; Lin Wang; Jing Su; Ruhui Zhang; Li Fu; Yanmin Zhou
Journal:  Oncol Lett       Date:  2013-05-17       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.